About
Gland Pharma Limited engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally. It engages in research and development of active pharmaceutical ingredient products, including synthesis of complex drug molecules, such as low molecular weight heparins, corticosteroids, peptides, and cytotoxic molecules. The company also offers its products for various therapeutic categories, such as anti- diabetic, anti-malarial, anti-infectives, anti-neoplastic, and neurological and central nervous system; blood related, ophthalmics and otologicals, cardiac, gastro-intestinal, and hormonal products; pain, neuromuscular blocking agents, and analgesics; respiratory and pulmonology; and vitamins, minerals, and nutrients. In addition, it provides contract development, dossier preparation, and technology transfer services. The company was incorporated in 1978 and is based in Hyderabad, India. Gland Pharma Limited operates as a subsidiary of Fosun Pharma Industrial Pte. Ltd.
Key Metrics
as of Sep 2026Market Cap48,426 Cr
P/E42.30
Div Yield0.68 %
Book Value₹629.00
52w High₹3,040.00
52w Low₹1,574.00
Face Value₹1.00
Quarterly Results
Rs. Crores · hover row for definition| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,287.00 | 1,262.00 | 1,178.00 | 1,074.00 | 1,039.00 | 1,030.00 | 1,011.00 | 1,063.00 | 1,012.00 | 1,175.00 | 1,098.00 | 1,011.00 | 884.00 |
| Expenses | 813.00 | 754.00 | 756.00 | 699.00 | 680.00 | 636.00 | 620.00 | 699.00 | 718.00 | 742.00 | 728.00 | 664.00 | 625.00 |
| Operating Profit | 474.00 | 508.00 | 422.00 | 375.00 | 359.00 | 394.00 | 391.00 | 364.00 | 294.00 | 433.00 | 369.00 | 347.00 | 259.00 |
| OPM % | 37.00 | 40.00 | 36.00 | 35.00 | 35.00 | 38.00 | 39.00 | 34.00 | 29.00 | 37.00 | 34.00 | 34.00 | 29.00 |
| Other Income | 59.00 | 106.00 | 36.00 | 83.00 | 55.00 | 44.00 | 65.00 | 58.00 | 48.00 | 47.00 | 43.00 | 41.00 | 35.00 |
| Depreciation | 44.00 | 43.00 | 45.00 | 45.00 | 44.00 | 43.00 | 44.00 | 42.00 | 41.00 | 43.00 | 40.00 | 40.00 | 39.00 |
| Interest | 1.00 | 6.00 | 0.00 | 4.00 | 7.00 | 3.00 | 18.00 | 0.00 | 1.00 | 5.00 | 1.00 | 1.00 | 2.00 |
| Profit before tax | 488.00 | 565.00 | 412.00 | 409.00 | 362.00 | 391.00 | 394.00 | 380.00 | 300.00 | 433.00 | 372.00 | 347.00 | 254.00 |
| Tax % | 25.00 | 26.00 | 25.00 | 26.00 | 26.00 | 26.00 | 25.00 | 26.00 | 26.00 | 26.00 | 26.00 | 26.00 | 26.00 |
| Net Profit | 364.00 | 420.00 | 308.00 | 302.00 | 269.00 | 290.00 | 295.00 | 282.00 | 223.00 | 321.00 | 277.00 | 258.00 | 188.00 |
| EPS in Rs | 22.09 | 25.52 | 18.69 | 18.33 | 16.34 | 17.60 | 17.91 | 17.10 | 13.53 | 19.51 | 16.81 | 15.64 | 11.39 |
Profit & Loss
Annual · Rs. Crores| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4,552.00 | 4,116.00 | 4,167.00 | 3,617.00 | 4,401.00 | 3,463.00 | 2,633.00 | 2,044.00 | 1,620.00 | 1,479.00 | 1,348.00 | 994.00 |
| Expenses | 2,889.00 | 2,674.00 | 2,758.00 | 2,598.00 | 2,890.00 | 2,161.00 | 1,678.00 | 1,338.00 | 1,085.00 | 854.00 | 845.00 | 678.00 |
| Operating Profit | 1,663.00 | 1,443.00 | 1,410.00 | 1,019.00 | 1,511.00 | 1,302.00 | 955.00 | 706.00 | 535.00 | 625.00 | 502.00 | 316.00 |
| OPM % | 37.00 | 35.00 | 34.00 | 28.00 | 34.00 | 38.00 | 36.00 | 35.00 | 33.00 | 42.00 | 37.00 | 32.00 |
| Other Income | 279.00 | 215.00 | 166.00 | 184.00 | 224.00 | 135.00 | 139.00 | 66.00 | 49.00 | 34.00 | 37.00 | 30.00 |
| Interest | 18.00 | 23.00 | 8.00 | 7.00 | 5.00 | 3.00 | 7.00 | 4.00 | 4.00 | 6.00 | 16.00 | 17.00 |
| Depreciation | 176.00 | 169.00 | 162.00 | 147.00 | 110.00 | 99.00 | 95.00 | 82.00 | 78.00 | 74.00 | 63.00 | 57.00 |
| Profit before tax | 1,748.00 | 1,466.00 | 1,405.00 | 1,048.00 | 1,619.00 | 1,335.00 | 993.00 | 686.00 | 502.00 | 578.00 | 459.00 | 272.00 |
| Tax % | 26.00 | 26.00 | 26.00 | 26.00 | 25.00 | 25.00 | 22.00 | 34.00 | 36.00 | 28.00 | 32.00 | 23.00 |
| Net Profit | 1,300.00 | 1,090.00 | 1,043.00 | 776.00 | 1,212.00 | 997.00 | 773.00 | 452.00 | 321.00 | 414.00 | 314.00 | 209.00 |
| EPS in Rs | 78.88 | 66.14 | 63.34 | 47.11 | 73.78 | 60.94 | 49.88 | 291.65 | 207.24 | 267.01 | 202.40 | 133.53 |
| Dividend Payout % | 25.00 | 27.00 | 32.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Balance Sheet
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | 15.00 | 16.00 |
| Reserves | 10,794.00 | 9,739.00 | 8,979.00 | 7,937.00 | 7,142.00 | 5,887.00 | 3,631.00 | 2,847.00 | 2,395.00 | 2,074.00 | 1,662.00 | 1,379.00 |
| Borrowings | 3.00 | 5.00 | 4.00 | 4.00 | 5.00 | 5.00 | 5.00 | 5.00 | 6.00 | 6.00 | 117.00 | 166.00 |
| Other Liabilities | 794.00 | 661.00 | 542.00 | 815.00 | 671.00 | 588.00 | 435.00 | 655.00 | 512.00 | 378.00 | 292.00 | 197.00 |
| Total Liabilities | 11,607.00 | 10,422.00 | 9,541.00 | 8,773.00 | 7,834.00 | 6,496.00 | 4,086.00 | 3,523.00 | 2,928.00 | 2,474.00 | 2,086.00 | 1,758.00 |
| Fixed Assets | 1,688.00 | 1,745.00 | 1,694.00 | 1,571.00 | 1,502.00 | 954.00 | 968.00 | 929.00 | 843.00 | 872.00 | 788.00 | 649.00 |
| CWIP | 138.00 | 42.00 | 120.00 | 177.00 | 191.00 | 338.00 | 188.00 | 123.00 | 199.00 | 161.00 | 202.00 | 192.00 |
| Investments | 3,293.00 | 2,790.00 | 2,386.00 | 8.00 | 163.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 6,489.00 | 5,845.00 | 5,342.00 | 7,017.00 | 5,978.00 | 5,203.00 | 2,929.00 | 2,471.00 | 1,887.00 | 1,441.00 | 1,096.00 | 917.00 |
| Total Assets | 11,607.00 | 10,422.00 | 9,541.00 | 8,773.00 | 7,834.00 | 6,496.00 | 4,086.00 | 3,523.00 | 2,928.00 | 2,474.00 | 2,086.00 | 1,758.00 |
Cash Flows
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 1,135.00 | 1,074.00 | 1,136.00 | 368.00 | 791.00 | 605.00 | 701.00 | 185.00 | 202.00 | 476.00 | 220.00 |
| Cash from Investing Activity | -74.00 | 1,582.00 | -2,918.00 | 1,211.00 | -1,007.00 | -1,521.00 | -761.00 | -319.00 | -359.00 | -100.00 | -12.00 |
| Cash from Financing Activity | -316.00 | -340.00 | -7.00 | 15.00 | 35.00 | 1,238.00 | -7.00 | -3.00 | -4.00 | -116.00 | -93.00 |
| Net Cash Flow | 745.00 | 2,316.00 | -1,789.00 | 1,594.00 | -181.00 | 322.00 | -67.00 | -136.00 | -160.00 | 260.00 | 115.00 |
| Free Cash Flow | 917.00 | 962.00 | 899.00 | 145.00 | 270.00 | 377.00 | 530.00 | 50.00 | 117.00 | 360.00 | 33.00 |
| CFO/OP % | 93.00 | 99.00 | 103.00 | 67.00 | 79.00 | 70.00 | 99.00 | 58.00 | 67.00 | 102.00 | 67.00 |
Ratios
Annual · Days / % — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 122.00 | 101.00 | 103.00 | 87.00 | 89.00 | 71.00 | 83.00 | 90.00 | 107.00 | 103.00 | 95.00 | 62.00 |
| Inventory Days | 257.00 | 265.00 | 253.00 | 421.00 | 205.00 | 312.00 | 250.00 | 388.00 | 283.00 | 271.00 | 248.00 | 283.00 |
| Days Payable | 99.00 | 81.00 | 56.00 | 128.00 | 80.00 | 97.00 | 82.00 | 190.00 | 161.00 | 136.00 | 60.00 | 58.00 |
| Cash Conversion Cycle | 280.00 | 284.00 | 299.00 | 381.00 | 214.00 | 286.00 | 251.00 | 289.00 | 229.00 | 239.00 | 283.00 | 288.00 |
| Working Capital Days | 209.00 | 249.00 | 224.00 | 241.00 | 168.00 | 169.00 | 161.00 | 191.00 | 185.00 | 154.00 | 155.00 | 141.00 |
| ROCE % | 17.00 | 16.00 | 17.00 | 15.00 | 25.00 | 28.00 | 30.00 | 27.00 | 22.00 | 30.00 | 28.00 | 22.00 |
Corporate Actions
4 records| Action | Ex Date | Record Date | Ratio | Amount (₹) | Notes |
|---|---|---|---|---|---|
| Dividend | 11 Aug 2026 | 11 Aug 2026 | — | 20.00 | |
| Dividend | 14 Aug 2025 | 14 Aug 2025 | — | 18.00 | |
| Dividend | 16 Aug 2024 | 16 Aug 2024 | — | 20.00 | |
| Other | 06 Aug 2021 | — | — | — | Annual General Meeting |
Announcements
5 filingsShareholding Pattern
Open on BSEFinancial Results — Filings
Open on BSEBoard Filings
Open on BSEAnnual Reports
Credit Ratings
-
Rating update6 Jun 2018 from fitch
-
Rating update17 Apr 2017 from fitch
-
Rating update23 Mar 2016 from fitch
-
Rating update28 Mar 2013 from fitch